Qvents

Qvents

Discussion forum for Pharma Quality events, Regulatory Actions

Warning letters, 483s, Recalls, Import Alerts, Audit observations

USFDA and EMA Parallel Scientific Advice

Prospective applicants of Complex Generics (CG) can request for a joint meeting with FDA OGD

EDQM New strategy for N-nitrosamine impu

European Pharmacopoeia Commission (EPC) approved the new strategy for N-nitrosamine impurities in individual monographs in

NATCO recalls Lansoprazole Capsules in U

Natco Pharma initiated a recall of one lot of Lanzoprazole 15mg capsules in US. Reason

FDA issues final guidance for annual rep

Each Drug Establishments (Registrants*) registered with FDA must provide information on amount of each listed

USFDA483 to Aurobindo’s Eugia US Site

USFDA audit of Eugia US Manufacturing in New Jersey, US (FEI 3015534630) resulted in issuance

FDA announces opportunity for drug manuf

The USFDA announced next phase of the Quality Management Maturity (QMM) Program for drug manufacturers.

Stagnant water in Equipment duct, Microb

Sun Pharma initiated recall of several drugs manufactured at Dadra site (India) for cGMP deviation

FDA announces GMP guideline for Veterina

The draft guidance Good Manufacturing Practice for Active Pharmaceutical Ingredients Used in Veterinary Medicinal Products

Dr.Reddy’s recall Tizanidine 4mg Table

Dr Reddys (DRL) initiated recall of one batch of Tizanidine 4mg tablets in US in

Risk of Nitrosamines, NDSRIs, Nitrosamin

Lupin recalled 3 batches of Desloratadine tablets in Dec 2023 for N-Nitroso Desloratadine impurity exceeding